- Home
- JCI vs IQV Comparison
JCI vs IQV Comparison
Compare JCI & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCI
- IQV
- Stock Information
- Founded
- JCI 1885
- IQV 1982
- Country
- JCI Ireland
- IQV United States
- Employees
- JCI N/A
- IQV N/A
- Industry
- JCI Industrial Machinery/Components
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- JCI Industrials
- IQV Health Care
- Exchange
- JCI Nasdaq
- IQV Nasdaq
- Market Cap
- JCI 47.1B
- IQV 38.1B
- IPO Year
- JCI N/A
- IQV 2013
- Fundamental
- Price
- JCI $84.41
- IQV $192.62
- Analyst Decision
- JCI Buy
- IQV Buy
- Analyst Count
- JCI 17
- IQV 16
- Target Price
- JCI $76.60
- IQV $259.40
- AVG Volume (30 Days)
- JCI 4.0M
- IQV 1.9M
- Earning Date
- JCI 11-06-2024
- IQV 10-31-2024
- Dividend Yield
- JCI 1.75%
- IQV N/A
- EPS Growth
- JCI N/A
- IQV 27.98
- EPS
- JCI 2.52
- IQV 7.62
- Revenue
- JCI $22,952,000,000.00
- IQV $15,315,000,000.00
- Revenue This Year
- JCI $8.64
- IQV $3.68
- Revenue Next Year
- JCI $4.10
- IQV $4.89
- P/E Ratio
- JCI $40.58
- IQV $25.29
- Revenue Growth
- JCI N/A
- IQV 3.10
- 52 Week Low
- JCI $51.41
- IQV $189.63
- 52 Week High
- JCI $87.16
- IQV $261.73
- Technical
- Relative Strength Index (RSI)
- JCI 66.69
- IQV 26.80
- Support Level
- JCI $84.56
- IQV $216.74
- Resistance Level
- JCI $87.16
- IQV $225.91
- Average True Range (ATR)
- JCI 1.75
- IQV 7.63
- MACD
- JCI 0.69
- IQV -1.28
- Stochastic Oscillator
- JCI 79.40
- IQV 8.24
About JCI Johnson Controls International plc
Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration units, and fire and security solutions. Commercial HVAC accounts for over 45% of sales, fire and security represents roughly 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 15% of revenue. In fiscal 2023, Johnson Controls generated nearly $27 billion in revenue.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.